Sangamo files June monthly operating report; cash $14.38M, net loss $3.76M in Chapter 11

SANGAMO THERAPEUTICS, INC

Chapter 11 filed June 23, 2026; case No. 26-10989 in Delaware; stock now OTC under SGMOQ.
Cash balance $14.38M at June 30, 2026; drew $10.5M under initial DIP facility during June.
June net loss $3.76M; gross income $108,953, G&A $1.10M, reorganization items $2.01M.
Prepetition unsecured debt $78.13M; total liabilities $89.15M; total assets $153.09M.
73 full-time employees as of June 30; professional fees and DIP financing approved by court.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.